CTKB FY 2024 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$200M+3.9% YoY

Gross Profit

$111M55.4% margin

Operating Income

-$21M-10.2% margin

Net Income

-$6M-3.0% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$22M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$500M

Total Liabilities

$104M

Stockholders' Equity

$396M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$200M	$193M	+3.9%
Gross Profit	$111M	$109M	+1.5%
Operating Income	-$21M	-$28M	+26.3%
Net Income	-$6M	-$12M	+50.4%